A hallmark of the CWRU/UHC research enterprise is a strong emphasis on international biomedical research with a particular interest in developing countries. The sixteen-year collaboration with Ugandan government and research facilities has fostered seminal studies of TB and HIV/AIDS. A major limitation to new initiatives in the developing world is the lack of state-of-the-art laboratory facilities on site. The longstanding research relationship between CWRU, the government of Uganda and Makerare University has resulted in the development of an extensive research infrastructure in Uganda. To facilitate sharing of these resources and to promote/support new research initiatives, all laboratory facilities and services associated with HIV/AIDS research are now being administered by the CWRU/UHC CFAR Uganda Laboratory Core with the following objectives: 1. provide comprehensive laboratory services to facilitate HIV/AIDS-related research projects of CFAR investigators 2. advertise these services, process requests, and coordinate research-based assays through the Uganda Laboratory Core 3. provide a mechanism for training of Ugandan scientists in collaboration with CWRU and Fogarty AIDS Training Grant Moving forward, the Ugandan Laboratory Core seeks to: 1. develop new assays to meet the needs of the CFAR investigators and improve the quality of HIV/AIDS research in Uganda 2. continue to engage Ugandan scientists/clinicians in research collaboration with CFAR members by promoting training scholarships, sponsoring workshops and meetings

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI036219-12
Application #
7063049
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
12
Fiscal Year
2005
Total Cost
$157,082
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Silver, Nicholas; Paynter, Mary; McAllister, Georgina et al. (2018) Characterization of minority HIV-1 drug resistant variants in the United Kingdom following the verification of a deep sequencing-based HIV-1 genotyping and tropism assay. AIDS Res Ther 15:18
Jiang, Wei; Luo, Zhenwu; Martin, Lisa et al. (2018) Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy. Curr HIV Res 16:143-150
Martinez, Leonardo; Handel, Andreas; Shen, Ye et al. (2018) A Prospective Validation of a Clinical Algorithm to Detect Tuberculosis in Child Contacts. Am J Respir Crit Care Med 197:1214-1216
Fitzgerald, Wendy; Freeman, Michael L; Lederman, Michael M et al. (2018) A System of Cytokines Encapsulated in ExtraCellular Vesicles. Sci Rep 8:8973
Dazard, Jean-Eudes; Ishwaran, Hemant; Mehlotra, Rajeev et al. (2018) Ensemble survival tree models to reveal pairwise interactions of variables with time-to-events outcomes in low-dimensional setting. Stat Appl Genet Mol Biol 17:
Mukherjee, Pranab K; Chandra, Jyotsna; Retuerto, Mauricio et al. (2018) Dysbiosis in the oral bacterial and fungal microbiome of HIV-infected subjects is associated with clinical and immunologic variables of HIV infection. PLoS One 13:e0200285
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372
Tomalka, Amanda G; Resto-Garay, Ivelisse; Campbell, Kerry S et al. (2018) In vitro Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells. Front Immunol 9:2552
Kalayjian, Robert C; Albert, Jeffrey M; Cremers, Serge et al. (2018) Women have enhanced bone loss associated with phosphaturia and CD4+ cell restoration during initial antiretroviral therapy. AIDS 32:2517-2524
AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018) Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32:2777-2786

Showing the most recent 10 out of 539 publications